Metabolic Risk Factors Are Associated with the Disease Severity and Prognosis of Hepatitis B Virus-Related Acute on Chronic Liver Failure
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: Metabolic risk factors could accelerate hepatitis B virus (HBV)-related mortality; however, their impacts on disease severity in HBV-related acute on chronic liver failure (HBV-ACLF) patients remain unexplored. In this study, we assessed the effects of metabolic risk factors on the outcome of HBV-ACLF patients. Methods: This study retrospectively enrolled antiviral therapy naïve HBV-ACLF patients from a single center in China. Patients were evaluated according to Child-Turcotte-Pugh score, Model for End-Stage Liver Disease (MELD) score, 30-day, 90-day mortality and survival rate to estimate the prognosis of HBV-ACLF. The impacts of different metabolic risk factors were further analyzed. Results: A total of 233 patients, including 158 (67.8%) with metabolic risk factors and 75 (32.2%) without metabolic risk factors, were finally analyzed. Patients with metabolic risk factors had significantly higher MELD score (22.6±6.1 vs 19.8±3.8, p<0.001), 90-day mortality rate (56.3% vs 38.7%, p=0.017), and shorter median survival time (58 days vs 75 days: hazard ratio, 1.553; 95% confidence interval, 1.061 to 2.274; p=0.036) than patients without them. Moreover, metabolic risk factors were independently associated with patients’ 90-day mortality (hazard ratio, 1.621; 95% confidence interval, 1.016 to 2.585; p=0.043). Prediabetes/diabetes and hypertension were related to higher rates of infection and worse renal function in HBV-ACLF patients. Conclusions: HBV-ACLF patients with metabolic risk factors, especially prediabetes/diabetes or hypertension, could have more severe disease and lower survival rates. In addition, the existence of metabolic disorder is an independent risk factor for HBV-ACLF patients’ 90-day mortality.
Abstract
Background/Aims: Metabolic risk factors could accelerate hepatitis B virus (HBV)-related mortality; however, their impacts on disease severity in HBV-related acute on chronic liver failure (HBV-ACLF) patients remain unexplored. In this study, we assessed the effects of metabolic risk factors on the outcome of HBV-ACLF patients. Methods: This study retrospectively enrolled antiviral therapy naïve HBV-ACLF patients from a single center in China. Patients were evaluated according to Child-Turcotte-Pugh score, Model for End-Stage Liver Disease (MELD) score, 30-day, 90-day mortality and survival rate to estimate the prognosis of HBV-ACLF. The impacts of different metabolic risk factors were further analyzed. Results: A total of 233 patients, including 158 (67.8%) with metabolic risk factors and 75 (32.2%) without metabolic risk factors, were finally analyzed. Patients with metabolic risk factors had significantly higher MELD score (22.6±6.1 vs 19.8±3.8, p<0.001), 90-day mortality rate (56.3% vs 38.7%, p=0.017), and shorter median survival time (58 days vs 75 days: hazard ratio, 1.553; 95% confidence interval, 1.061 to 2.274; p=0.036) than patients without them. Moreover, metabolic risk factors were independently associated with patients’ 90-day mortality (hazard ratio, 1.621; 95% confidence interval, 1.016 to 2.585; p=0.043). Prediabetes/diabetes and hypertension were related to higher rates of infection and worse renal function in HBV-ACLF patients. Conclusions: HBV-ACLF patients with metabolic risk factors, especially prediabetes/diabetes or hypertension, could have more severe disease and lower survival rates. In addition, the existence of metabolic disorder is an independent risk factor for HBV-ACLF patients’ 90-day mortality.
참고문헌 (35)
- Wang H, "Hepatitis B infection in the general population of China : a systematic review and metaanalysis", BMC Infect Dis, 19, pp.811~ (2019)
- Machado MV, "Hepatic steatosis in hepatitis B virus infected patients : meta-analysis of risk factors and comparison with hepatitis C infected patients", J Gastroenterol Hepatol, 26, pp.1361~1367 (2011)
- Lim CT, "Presence of hepatic steatosis does not increase the risk of hepatocellular carcinoma in patients with chronic hepatitis B over long follow-up", Microbiol Insights, 13, pp.1178636120918878~ (2020)
- Gao H, "Prevalence and risk factors of nonalcoholic fatty liver disease in patients with chronic hepatitis B receiving antiviral therapy", Zhonghua Gan Zang Bing Za Zhi, 27, pp.347~351 (2019)
- Peleg N, "Liver steatosis is a strong predictor of mortality and cancer in chronic hepatitis B regardless of viral load", JHEP Rep, 1, pp.9~16 (2019)
- Yun Bin Lee, "Association between hepatic steatosis and the development of hepatocellular carcinoma in patients with chronic hepatitis B", Clinical and Molecular Hepatology, 25(1), pp.52~64 (2019), 대한간학회
- Choi HS, "Nonalcoholic steatohepatitis is associated with liver-related outcomes and all-cause mortality in chronic hepatitis B", Hepatology, 71, pp.539~548 (2020)
- Chen CL, "Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B", C infection : a follow-up study in Taiwan, 2008, pp.135, 111~121
- Karacaer Z, "Is there an influence of hepatic steatosis on fibrosis and necroinflammation in young patients with chronic viral hepatitis B?", Postgrad Med, 128, pp.697~700 (2016)
- Arroyo V, "Acute-on-chronic liver failure : a new syndrome that will re-classify cirrhosis", J Hepatol, 62(1Suppl), pp.S131~S143 (2015)
- Sarin SK, "Acute-on-chronic liver failure : consensus recommendations of the Asian Pacific Association for the Study of the Liver(APASL) : an update", Hepatol Int, 13, pp.353~390 (2019)
- Shi Y, "Acute-on-chronic liver failure precipitated by hepatic injury is distinct from that precipitated by extrahepatic insults", Hepatology, 62, pp.232~242 (2015)
- Li H, "Characteristics, diagnosis and prognosis of acute-on-chronic liver failure in cirrhosis associated to hepatitis B", Sci Rep, 6, pp.25487~ (2016)
- Ren X, "Hepatitis B virus genotype and basal core promoter", precore mutations are associated with hepatitis B-related acute-on-chronic liver failure without pre-existing liver cirrhosis, 2010, pp.17, 887~895
- Zhai XR, "Infection deteriorating hepatitis B virus related acute-on-chronic liver failure : a retrospective cohort study", BMC Gastroenterol, 20, pp.320~ (2020)
- Yuan W, "Risk factors and outcomes of acute kidney injury in patients with hepatitis B virus-related acute-on-chronic liver failure", Am J Med Sci, 353, pp.452~458 (2017)
- Hazlehurst JM, "Non-alcoholic fatty liver disease and diabetes", Metabolism, 65, pp.1096~1108 (2016)
- Koye DN, "The global epidemiology of diabetes and kidney disease", Adv Chronic Kidney Dis, 25, pp.121~132 (2018)
- Casqueiro J, "Infections in patients with diabetes mellitus : a review of pathogenesis", Indian J Endocrinol Metab, 16(Suppl1), pp.S27~S36 (2012)
- Tang LS, "Chronic hepatitis B infection : a review", JAMA, 319, pp.1802~1813 (2018)
- Wu T, "Development of diagnostic criteria and a prognostic score for hepatitis B virus-related acute-onchronic liver failure", Gut, 67, pp.2181~2191 (2018)
- Sarin SK, "Acute-on-chronic liver failure : consensus recommendations of the Asian Pacific Association for the Study of the Liver(APASL)2014", Hepatol Int, 8, pp.453~471 (2014)
- WHO Expert Consultation, "Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies", Lancet, 363, pp.157~163 (2004)
- Grundy SM, "Diagnosis and management of the metabolic syndrome : an American Heart Association", National Heart, Lung, and Blood Institute Scientific Statement, 2005, pp.112, 2735~2752
- American Diabetes Association, "Diagnosis and classification of diabetes mellitus", Diabetes Care, 37(Suppl 1), pp.S81~S90 (2014)
- Unger T, "2020 International Society of Hypertension global hypertension practice guidelines", Hypertension, 75, pp.1334~1357 (2020)
- Seto WK, "Association between hepatic steatosis, measured by controlled attenuation parameter, and fibrosis burden in chronic hepatitis B", Clin Gastroenterol Hepatol, 16, pp.575~583 (2018)
- Yu MW, "Influence of metabolic risk factors on risk of hepatocellular carcinoma and liver-related death in men with chronic hepatitis B : a large cohort study", Gastroenterology, 153, pp.1006~1017 (2017)
- Lee YB, "Association of metabolic risk factors with risks of cancer and all-cause mortality in patients with chronic hepatitis B", Hepatology, 73, pp.2266~2277 (2021)
- Duseja A, "Impact of metabolic risk factors on the severity and outcome of patients with alcohol-associated acute-on-chronic liver failure", Liver Int, 41, pp.150~157 (2021)
- Shyu YC, "Diabetes poses a higher risk of hepatocellular carcinoma and mortality in patients with chronic hepatitis B : a populationbased cohort study", J Viral Hepat, 26, pp.718~726 (2019)
- Bajaj JS, "Prediction of fungal infection development and their impact on survival using the NACSELD cohort", Am J Gastroenterol, 113, pp.556~563 (2018)
- Younossi ZM, "Global epidemiology of nonalcoholic fatty liver disease : meta-analytic assessment of prevalence, incidence, and outcomes", Hepatology, 64, pp.73~84 (2016)
- Sundaram V, "Acute on chronic liver failure from nonalcoholic fatty liver disease : a growing and aging cohort with rising mortality", Hepatology, 73, pp.1932~1944 (2021)
- Kanwal S, "Frequency of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus and its associated risk factors", Pak J Med Sci, 37, pp.1335~1341 (2021)